We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$224B
AUM Growth
+$21B
Cap. Flow
+$7.48B
Cap. Flow %
3.33%
Top 10 Hldgs %
24.57%
Holding
10,190
New
1,427
Increased
4,227
Reduced
3,278
Closed
1,044

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$798M
2
T icon
AT&T
T
+$527M
3
MCHP icon
Microchip Technology
MCHP
+$472M
4
NFLX icon
Netflix
NFLX
+$446M
5
PNC icon
PNC Financial Services
PNC
+$444M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$694M
2
KEY icon
KeyCorp
KEY
+$401M
3
DE icon
Deere & Co
DE
+$322M
4
CSX icon
CSX Corp
CSX
+$318M
5
NXPI icon
NXP Semiconductors
NXPI
+$314M

Sector Composition

Rank Sector Weight
1 Financials 5.93%
2 Technology 4.66%
3 Healthcare 4.45%
4 Industrials 4.14%
5 Consumer Discretionary 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCEL icon
8551
CALL
FuelCell Energy
FCEL
$1.81B
$69K ﹤0.01%
178
+69
+63% +$29.8K
GSIT icon
8552
PUT
GSI Technology
GSIT
$269M
$69K ﹤0.01%
+10,000
New +$68.6K
KNDI
8553
Kandi Technologies Group
KNDI
$62.3M
$69K ﹤0.01%
14,262
-5,224
-27% -$22.2K
ARTX
8554
DELISTED
Arotech Corporation
ARTX
$69K ﹤0.01%
20,303
+8,797
+76% +$31.5K
CELH icon
8555
Celsius Holdings
CELH
$7.24B
$68K ﹤0.01%
50,346
+11,079
+28% +$16.3K
DXR icon
8556
Daxor
DXR
$60.7M
$68K ﹤0.01%
+13,545
New +$74.5K
CCEC
8557
Capital Clean Energy Carriers
CCEC
$1.36B
$68K ﹤0.01%
3,499
-3,655
-51% -$76.4K
ATHX
8558
CALL
DELISTED
Athersys, Inc. Common Stock
ATHX
$68K ﹤0.01%
1,296
+712
+122% +$35.3K
CHKR
8559
CALL
DELISTED
CHESAPEAKE GRANITE WASH TRUST
CHKR
$68K ﹤0.01%
41,300
-2,800
-6% -$4.67K
CARM
8560
PUT
DELISTED
Carisma Therapeutics
CARM
$67K ﹤0.01%
1,560
-2,315
-60% -$90.2K
MGNI icon
8561
Magnite
MGNI
$3.52B
$67K ﹤0.01%
18,604
+3,922
+27% +$13.9K
PACB icon
8562
CALL
Pacific Biosciences
PACB
$364M
$67K ﹤0.01%
12,400
-5,500
-31% -$23.6K
QHC
8563
PUT
DELISTED
Quorum Health Corporation
QHC
$67K ﹤0.01%
+11,500
New +$52.9K
HOS
8564
CALL
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$67K ﹤0.01%
11,400
-12,600
-53% -$57.8K
AREX
8565
DELISTED
Approach Resources Inc.
AREX
$67K ﹤0.01%
29,945
-45,502
-60% -$103K
CYTR
8566
CALL
DELISTED
CytRx Corp
CYTR
$67K ﹤0.01%
63,900
+30,500
+91% +$34.4K
SPWH icon
8567
CALL
Sportsman's Warehouse
SPWH
$46.8M
$66K ﹤0.01%
11,300
-400
-3% -$2.18K
ALTO icon
8568
CALL
Alto Ingredients
ALTO
$327M
$65K ﹤0.01%
34,000
-6,100
-15% -$13.6K
BCLI
8569
CALL
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$65K ﹤0.01%
1,140
-493
-30% -$29.8K
CPRX
8570
DELISTED
Catalyst Pharmaceutical
CPRX
$65K ﹤0.01%
17,268
+3,217
+23% +$10.1K
CRNT icon
8571
PUT
Ceragon Networks
CRNT
$197M
$65K ﹤0.01%
19,300
-1,800
-9% -$6.12K
EYPT icon
8572
EyePoint Inc
EYPT
$1.22B
$65K ﹤0.01%
+1,808
New +$41.5K
EYPT icon
8573
PUT
EyePoint Inc
EYPT
$1.22B
$65K ﹤0.01%
1,830
+680
+59% +$15.6K
VJET
8574
CALL
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
$65K ﹤0.01%
+2,920
New +$54.6K
SHLD
8575
DELISTED
Sears Holding Corporation
SHLD
$65K ﹤0.01%
67,116
-3,394
-5% -$5.66K

Similar funds

Ken Griffin's Q3 2018 Portfolio in Review

As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.

By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.

  • Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
  • Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
  • Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
  • Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
  • Ken Griffin opened 1,427 new positions and closed 1,044 in Q3 2018.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.

Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.